Actively Recruiting
Analysis of Prevalence and Risk Factors Associated With Gastroesophageal Reflux Disease and Esophagitis After Peroral Endoscopic Myotomy
Led by Maria Sklodowska-Curie National Research Institute of Oncology · Updated on 2021-10-18
100
Participants Needed
1
Research Sites
274 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Achalasia is an uncommon disorder that results from the degeneration of ganglion cells of the myenteric plexus in the lower esophageal wall. Peroral endoscopic myotomy (POEM) is a minimally invasive procedure capable of overcoming limitations of achalasia treatments. This study aimed to: 1) identify the prevalence of reflux esophagitis and asymptomatic GERD in patients who underwent POEM, and 2) evaluate patient and intraprocedural variables associated with post-POEM GERD.
CONDITIONS
Official Title
Analysis of Prevalence and Risk Factors Associated With Gastroesophageal Reflux Disease and Esophagitis After Peroral Endoscopic Myotomy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Males and females 18 years of age or older who agree to sign an informed consent form
- Diagnosed achalasia patients who have undergone peroral endoscopic myotomy (POEM)
You will not qualify if you...
- Not providing written consent for study participation
- Having conditions that prevent safe use of esophagogastroscopy or high-resolution esophageal manometry
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Maria Sklodowska-Curie Institute - Oncology Center
Warsaw, Poland
Actively Recruiting
Research Team
A
Anna Chaber-Ciopińska, PhD
CONTACT
A
Aleksandra Budnicka-Borkowicz, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here